Indian court clears export of patented Bayer drugs for research

25-04-2019

Indian court clears export of patented Bayer drugs for research

photobyphm / Shutterstock.com

The Delhi High Court has cleared two Indian drug companies to export a cancer drug and blood thinner, both patented by Bayer, for the purposes of development and clinical trials for regulatory clearances.


Delhi High Court, Alembic Pharmaceuticals, Bayer, Natco Pharma, Xarelto, Nexavar, export, patent infringement

LSIPR